Cases & Deals

  • Home
  • Practices
  • Baxter International invests in Bugworks Research

Share

Baxter International invests in Bugworks Research

November 2015

Client(s) Baxter International Inc.

Jones Day represented Baxter International Inc. in connection with its purchase of Series Seed Preferred Stock in a private placement by Bugworks Research, Inc., a discovery company that aims to discover novel biopharmaceutical assets for the treatment of antibiotic resistant bacterial infections.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.